AUTX-703

A Phase 1 Study of AUTX-703 in Participants With Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes

Arms / Cohorts

Experimental:Dose Escalation - Part A

Accepting patients

Experimental:Dose Optimization - Part B, Dosage 1

Accepting patients

Experimental:Dose Optimization - Part B, Dosage 2

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.